Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 12/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | PDE9A | O76083 | 1/20 | 0.33 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21899766 | 0.96 | AR (0.43) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL20611853 | 0.94 | AR (0.48) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL20623814 | 0.93 | AR (0.50) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL20623507 | 0.93 | AR (0.42) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL21898491 | 0.93 | AR (0.40) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL21898548 | 0.92 | KDM4E (0.38) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL20624004 | 0.91 | KIF11 (0.44) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL21899816 | 0.91 | AR (0.46) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL20623719 | 0.90 | AR (0.36) | ARHPGDALDH1A1GLAGAA | |
| SCHEMBL21899767 | 0.89 | AR (0.43) | ARHPGDALDH1A1GLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11661412-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-30 | — | — | US | disclosed |
| EP-3645523-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2022-08-03 | — | — | EP | disclosed |
| US-20200123131-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123131-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, AOC3, MT-CO3 | AR 4468/4885HPGD 1739/4885ALDH1A1 660/4885 |
| US-11661412-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, AOX1 | AR 4596/4885HPGD 877/4885ALDH1A1 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.